JP2010511019A5 - - Google Patents

Download PDF

Info

Publication number
JP2010511019A5
JP2010511019A5 JP2009538726A JP2009538726A JP2010511019A5 JP 2010511019 A5 JP2010511019 A5 JP 2010511019A5 JP 2009538726 A JP2009538726 A JP 2009538726A JP 2009538726 A JP2009538726 A JP 2009538726A JP 2010511019 A5 JP2010511019 A5 JP 2010511019A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkyl
compound
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009538726A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010511019A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/063108 external-priority patent/WO2008065199A1/en
Publication of JP2010511019A publication Critical patent/JP2010511019A/ja
Publication of JP2010511019A5 publication Critical patent/JP2010511019A5/ja
Pending legal-status Critical Current

Links

JP2009538726A 2006-12-01 2007-11-30 変性疾患及び炎症性疾患の治療に有用なイミダゾロピリジン化合物 Pending JP2010511019A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86814906P 2006-12-01 2006-12-01
US99474007P 2007-09-21 2007-09-21
PCT/EP2007/063108 WO2008065199A1 (en) 2006-12-01 2007-11-30 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases

Publications (2)

Publication Number Publication Date
JP2010511019A JP2010511019A (ja) 2010-04-08
JP2010511019A5 true JP2010511019A5 (enExample) 2010-12-09

Family

ID=39047973

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009538726A Pending JP2010511019A (ja) 2006-12-01 2007-11-30 変性疾患及び炎症性疾患の治療に有用なイミダゾロピリジン化合物

Country Status (4)

Country Link
US (2) US7951818B2 (enExample)
EP (1) EP2099798A1 (enExample)
JP (1) JP2010511019A (enExample)
WO (1) WO2008065199A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010511018A (ja) * 2006-12-01 2010-04-08 ガラパゴス・ナムローゼ・フェンノートシャップ 変性疾患及び炎症性疾患の治療に有用なトリアゾロピリジン化合物
US7951818B2 (en) * 2006-12-01 2011-05-31 Galapagos Nv Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
AU2009305005A1 (en) * 2008-10-14 2010-04-22 Actelion Pharmaceuticals Ltd Phenethylamide derivatives and their heterocyclic analogues
EP3552607A3 (en) 2008-12-08 2020-01-15 Gilead Connecticut, Inc. Imidazopyrazine syk inhibitors
PA8854101A1 (es) * 2008-12-18 2010-07-27 Ortho Mcneil Janssen Pharm Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
US8946426B2 (en) 2009-02-06 2015-02-03 Janssen Pharmaceuticals, Inc. Substituted bicyclic heterocyclic compounds as gamma secretase modulators
TWI461425B (zh) 2009-02-19 2014-11-21 Janssen Pharmaceuticals Inc 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
ES2431619T3 (es) 2009-05-07 2013-11-27 Janssen Pharmaceuticals, Inc. Derivados de indazol y aza-indazol sustituidos como moduladores de gamma-secretasa
NZ597505A (en) 2009-07-15 2013-05-31 Janssen Pharmaceuticals Inc Substituted triazole and imidazole derivatives as gamma secretase modulators
US9145399B2 (en) 2010-01-15 2015-09-29 Janssen Pharmaceuticals, Inc. Substituted bicyclic triazole derivatives as gamma secretase modulators
US9562056B2 (en) * 2010-03-11 2017-02-07 Gilead Connecticut, Inc. Imidazopyridines Syk inhibitors
ES2536442T3 (es) 2011-03-24 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados novedosos de triazolil piperazina y triazolil piperidina como moduladores de la gamma secretasa
JP6068464B2 (ja) 2011-07-15 2017-01-25 ヤンセン ファーマシューティカルズ,インコーポレーテッド γ−セクレターゼ調節剤としての新規な置換インドール誘導体
ES2585009T3 (es) 2012-05-16 2016-10-03 Janssen Pharmaceuticals, Inc. Derivados de 3,4-dihidro-2H-pirido[1,2-a]pirazina-1,6-diona sustituidos útiles para el tratamiento de (inter alia) enfermedad de Alzheimer
CA2889249C (en) 2012-12-20 2021-02-16 Francois Paul Bischoff Tricyclic 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives as gamma secretase modulators
AU2014206834B2 (en) 2013-01-17 2017-06-22 Janssen Pharmaceutica Nv Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
CN107129496A (zh) * 2017-06-02 2017-09-05 贵州大学 一种8‑碘‑6‑硝基‑咪唑并[1,2‑a]吡啶的制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
WO2004014908A1 (en) * 2002-08-13 2004-02-19 Warner-Lambert Company Llc Heterobicylcic metalloproteinase inhibitors
AR041291A1 (es) 2002-09-19 2005-05-11 Schering Corp Imidazopiridinas como inhibidores de quinasa dependientes de ciclina
MXPA06014637A (es) * 2004-06-25 2007-02-12 Amgen Inc Triazoles e indazoles condensados utiles en el tratamiento de enfermedades mediadas por citocinas y otras enfermedades.
US7893058B2 (en) 2006-05-15 2011-02-22 Janssen Pharmaceutica Nv Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
US7951818B2 (en) * 2006-12-01 2011-05-31 Galapagos Nv Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases

Similar Documents

Publication Publication Date Title
JP2010511019A5 (enExample)
JP2010511018A5 (enExample)
JP2013507425A5 (enExample)
RU2353616C2 (ru) Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение
JP2018511647A5 (enExample)
JP2013532652A5 (enExample)
JP2006524660A5 (enExample)
EP1915994B1 (en) Cyclic amine derivatives in combination with ppar regulators
JP2005534669A5 (enExample)
JP2018520195A5 (enExample)
RU2013108348A (ru) Конденсированные гетероарилы и их применение
RU2005122901A (ru) Производные пиридино [2,3-] пиримидина в качестве селективных ингибиторов kdr и fgfr
AR067824A1 (es) Compuestos de acido boronico y ester boronico inhibidores de la proteasoma, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento del cancer.
JP2013523614A5 (enExample)
JP2011509309A5 (enExample)
HRP20171189T1 (hr) Bisaril-vezani ariltriazoloni i njihova uporaba
JP2013520443A5 (enExample)
JP2014520898A5 (enExample)
KR920021541A (ko) 벤조푸란 유도체
JP2005505618A5 (enExample)
RU2019100164A (ru) Гетероциклическое соединение, используемое как ингибитор fgfr
CA2514384A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
RU2013141274A (ru) Содержащие фосфор соединения в качестве ингибиторов протеинкиназ
RU2010117156A (ru) Гетероциклические соединения в качестве антагонистов crth2 рецептора
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она